Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More
 

Antibody


9919 Results Advanced Search  
Showing
Can't Find What You're Looking For?
Contact Customer Service

 
  • Small GTPase Activation Assays | Life Science Research | Merck

    Cytoskeletal signaling complexes include G-protein complexes, focal adhesions, and adherens junctions. Focal adhesions and adherens junctions link the cell exterior to the plasma membrane and the actin cytoskeleton, acting as key initiators of signaling pathways in response to cell adhesion.
  • RIPAb+ | Life Science Research | Merck

    All RIPAb+ antibodies are validated for RNA-binding protein immunoprecipitation. Each RIPAb+ antibody set includes control primers (each lot tested by qPCR) to biologically validate your RNA RIP results by qPCR detection of specific RNAs where possible
  • Protein Phosphorylation | Life Science Research | Merck

    Protein phosphorylation systems are composed of at least three components: (a) phosphoproteins (b) kinases and (c) phosphatases, that dephosphorylate the phosphoproteins, thereby restoring the system to its basal stage.
  • Histone Peptide Arrays | Life Science Research | Merck

    Histone peptide arrays are essential screening tools to evaluate the specificity and cross-reactivity of antibodies against histones H2A, H2B, H3, H4, and their post-translational modifications.The arrays are designed on PVDF membranes for a simple Western blot-like assay.
  • ChIP Ab+ | Life Science Research | Merck

    ChIP Ab+ antibodies avoid ChIP failure due to poor antibody performance. Each ChIPAb+ antibody set includes control primers to validate your ChIP results and a negative control antibody to confirm specificity of the reaction.
  • New Antibodies and Small Molecules | Life Science Research | Merck

    Merck develops new antibodies and small molecules to support advance research. Scientist needs precise, dependable antibodies to study the latest targets and discover new molecules. At Merck, our scientists evaluate potential antibody targets to determine if our customers can benefit from new antibody target developments. We then work to produce specific, validated antibodies for success in various research applications.